Atlas Trials

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Clinical trial NCT03775200 · COMPLETED

Trial details

NCT number
NCT03775200
Sponsor
COMPASS Pathways
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Depression
Start date
2019-03-01
Primary completion
2021-07-30
Enrollment
233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.